Cargando…
Clinical features of children with polycythemia vera, essential thrombocythemia, and primary myelofibrosis in Japan: A retrospective nationwide survey
BACKGROUND: Philadelphia‐negative (Ph‐negative) myeloproliferative neoplasms (MPNs), including polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF), are exceptionally rare during childhood. Thus, clinical features of pediatric Ph‐negative MPNs remain largely unknow...
Autores principales: | Ishida, Hisashi, Miyajima, Yuji, Hyakuna, Nobuyuki, Hamada, Satoru, Sarashina, Takeo, Matsumura, Risa, Umeda, Katsutsugu, Mitsui, Tetsuo, Fujita, Naoto, Tomizawa, Daisuke, Urayama, Kevin Y., Ishida, Yasushi, Taga, Takashi, Takagi, Masatoshi, Adachi, Souichi, Manabe, Atsushi, Imamura, Toshihiko, Koh, Katsuyoshi, Shimada, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175656/ https://www.ncbi.nlm.nih.gov/pubmed/35847744 http://dx.doi.org/10.1002/jha2.39 |
Ejemplares similares
-
Longitudinal trends of peripheral blood counts in polycythaemia vera and essential thrombocythemia patients in the UK
por: Carpenter, Lewis, et al.
Publicado: (2022) -
Incidence of blast phase in myelofibrosis according to anemia severity
por: Mora, Barbara, et al.
Publicado: (2023) -
Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study
por: Ayala, Rosa, et al.
Publicado: (2023) -
The importance of cytogenetics in polycythemia vera, primary myelofibrosis and essential thrombocythemia
por: Conchon, Monika
Publicado: (2011) -
Population pharmacokinetics of fedratinib in patients with myelofibrosis, polycythemia vera, and essential thrombocythemia
por: Ogasawara, Ken, et al.
Publicado: (2019)